Abstract 14181: Aldosterone Synthase Inhibitors in Adequate Blood Pressure Control in Uncontrolled/Resistant Hypertension: A Meta-Analysis of Randomized Controlled Trials
Introduction: Uncontrolled/Resistant hypertension affects 10-20% of hypertensive patients and carries elevated cardiovascular risk. Aldosterone Synthase Inhibitors (ASIs) selectively inhibit CYP11B2, offering targeted aldosterone suppression without glucocorticoid interference. We conducted a meta-analysis of random...